Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May act as a protease inhibitor to modulate the host immune response against tumor cells.. Additionally we are shipping SERPINB3 Proteins (14) and SERPINB3 Kits (7) and many more products for this protein.
Showing 10 out of 116 products:
Human Monoclonal SERPINB3 Primary Antibody for IHC, WB - ABIN2731774
Zhao, Duan, Yuan, Quan, Yang, Xi: A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array. in International journal of nanomedicine 2014
iron overload and was previously found capable of up-regulating SerpinB3 at the transcriptional level.
the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.
Serum SCC (show CYP11A1 Antibodies)-Ag, hs-CRP (show CRP Antibodies), and CA-125 (show MUC16 Antibodies) were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.
A close connection between SerpinB3 and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.
Findings point to potential interest of squamous cell carcinoma antigen SERPINB3/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.
role of SERPINB3/B4 mutations in immunotherapy response
Data show that in colorectal cancer SerpinB3, COX-2 (show COX2 Antibodies) and beta-Catenin (show CTNNB1 Antibodies) are positively correlated and associated with more advanced tumor stage.
Results showed no correlation between gestational age and vaginal fluid SCC (show CYP11A1 Antibodies) levels. There was no significant difference in vaginal fluid SCC (show CYP11A1 Antibodies) levels between patients with premature rupture of membranes and those with control pregnant women.
Serum SCC (show CYP11A1 Antibodies)-Ag level was an important predictor for the cervical squamous carcinoma recurrence and prognosis.
Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 (show KRT19 Antibodies) fragment), S-SCCA and S-CEA (show CEACAM5 Antibodies).
May act as a protease inhibitor to modulate the host immune response against tumor cells.
, serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3
, serpin B3
, squamous cell carcinoma antigen 1
, serine protease inhibitor B3